Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year
Merck reports Q4 2025 earnings Feb. 3 before market; Street expects $2.01 EPS on $16.12B revenue; Keytruda, Gardasil, guidance and Verona integration are focus.
Peer-reviewed research reveals HORRIFIC HEALTH OUTCOMES from the HPV vaccine, including autonomic dysfunction, menstrual irregularities (POTS) and death
The HPV vaccine shows concerning links to serious side effects, including autonomic dysfunction and menstrual irregularities, particularly among young women.